Bionic Sight, Inc. is a biotech company that is developing next generation optogenetic gene therapies. The mission is to improve the lives of patients with retinal and neurodegenerative diseases.
 

The company was founded by Dr. Sheila Nirenberg, a professor at the Weill Medical College of Cornell University, and builds on her work on retinal degenerative and neurodegenerative diseases and computer vision. Her work on deciphering the retina's neural code and using it to restore visual function has earned her several awards including a MacArthur "genius" award.
 

The company's current focus is on an optogenetic treatment with a novel mechanism of action that has the potential to improve or restore vision in patients with retinitis pigmentosa (RP), geographic atrophy (GA), Stargardt's disease, choroideremia, and other retinal degenerative diseases.